Gonococcal antimicrobial susceptibility surveillance in Europe, 2013

surveillance report external quality assessment
Publication series: Gonococcal antimicrobial susceptibility surveillance in Europe
Time period covered: 1 January - 31 December 2013
Cite:
Citation Link

European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe, 2013. Stockholm: ECDC; 2015.

Copy citation to clipboard

​During 2013, the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) followed the biannual decentralised and centralised testing model used in previous years, requesting participating laboratories to collect gonococcal isolates during two periods (April/May and October/November). Twenty-one countries participated in the gonococcal antimicrobial resistance external quality assessment (EQA) scheme and the EQA continued to show high comparability between participants, raising confidence in the quality and comparability of the gonococcal antimicrobial susceptibility testing in Euro-GASP.

Publication data

Data

Distribution of minimum inhibitory concentration for cefixime in Euro-GASP 2009-13

data, graph -
Period: 01 Jan 2009 - 31 Dec 2013

Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Distribution of minimum inhibitory concentration for cefixime in Euro-GASP 2009-13

Data

Distribution of minimum inhibitory concentration for ceftriaxone in Euro-GASP 2004-13

data, graph -
Period: 01 Jan 2004 - 31 Dec 2013

Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Distribution of minimum inhibitory concentration for ceftriaxone in Euro-GASP 2004-13

Data

Overall percentage of resistant Neisseria gonorrhoeae by antimicrobial year Euro-GASP 2004-13

data, graph -
Period: 01 Jan 2004 - 31 Dec 2013

Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Overall percentage of resistant Neisseria gonorrhoeae by antimicrobial year Euro-GASP 2004-13

Data

Percentage of isolates with azithromycin resistance by gender male sexual orientation Euro-GASP 2009-13

data, graph -
Period: 01 Jan 2009 - 31 Dec 2013

Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Percentage of isolates with azithromycin resistance by gender male sexual orientation Euro-GASP 2009-13

Data

Percentage of isolates with cefixime resistance by gender male sexual orientation Euro-GASP 2009-13

data, graph -
Period: 01 Jan 2009 - 31 Dec 2013

Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Percentage of isolates with cefixime resistance by gender male sexual orientation Euro-GASP 2009-13

Data

Percentage of isolates with ciprofloxacin resistance by gender male sexual orientation Euro-GASP 2009-13

data, graph -
Period: 01 Jan 2009 - 31 Dec 2013

Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Percentage of isolates with ciprofloxacin resistance by gender male sexual orientation Euro-GASP 2009-13

Data

Resistance to cefixime, ciprofloxacin, azithromycin and penicillin G by country Euro-GASP 2013

data, table -
Period: 01 Jan 2013 - 31 Dec 2013

Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Resistance to cefixime, ciprofloxacin, azithromycin and penicillin G by country Euro-GASP 2013

Data

Resistance to cefixime, ciprofloxacin, azithromycin and penicillin G by patient characteristics Euro-GASP 2013

data, table -
Period: 01 Jan 2013 - 31 Dec 2013

Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Resistance to cefixime, ciprofloxacin, azithromycin and penicillin G by patient characteristics Euro-GASP 2013